Clinical and Life Sciences · 30 September 2026 to 30 September 2026 · 1 headlines · MedPage Today
SERD Combination Slows Breast Cancer After CDK4/6 Inhibitor Progression
A SERD-based drug combination slowed progression of breast cancer in patients whose disease had advanced after treatment with a CDK4/6 inhibitor.
As it ran
30 September 2026
More from US healthcare
- SSM Health names Wisconsin regional president 30 September 2026
- Sepsis in Pregnancy Is a Deadly Combo: Here's Who's at Risk 30 September 2026
- America’s biotech race with China must be won at home 30 September 2026
- CAR-T Therapy Shows Durable Benefits in Myasthenia Gravis 30 September 2026
- Deals tracker: Sharp Healthcare partners with DISC Surgery Center 30 September 2026
- Drugs Are Widely Used To Sedate Dementia Patients. Her Sons Wanted To Keep Her Off Them. 30 September 2026
- “Here to Stay”: 3 Providers on The Future of AI in ABA Therapy 30 September 2026
- HOPDs' higher drug payment rates drive $12.7B in spending: EBRI 30 September 2026